Page last updated: 2024-08-26

sr141716 and betadex

sr141716 has been researched along with betadex in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Liao, YS; Wang, P; Wu, J; Zhang, H	1

Other Studies

1 other study(ies) available for sr141716 and betadex

Article	Year
[Anandamide inhibits the growth of colorectal cancer cells through CB1 and lipid rafts]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2011, Volume: 33, Issue:4 Topics: Antineoplastic Agents; Apoptosis; Arachidonic Acids; beta-Cyclodextrins; Caco-2 Cells; Cannabinoid Receptor Modulators; Caspase 3; Cell Proliferation; Dose-Response Relationship, Drug; Endocannabinoids; Humans; Indoles; Membrane Microdomains; Piperidines; Polyunsaturated Alkamides; Proto-Oncogene Proteins c-akt; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant	2011

Article

Year

[Anandamide inhibits the growth of colorectal cancer cells through CB1 and lipid rafts].

Zhonghua zhong liu za zhi [Chinese journal of oncology], 2011, Volume: 33, Issue:4

Topics: Antineoplastic Agents; Apoptosis; Arachidonic Acids; beta-Cyclodextrins; Caco-2 Cells; Cannabinoid Receptor Modulators; Caspase 3; Cell Proliferation; Dose-Response Relationship, Drug; Endocannabinoids; Humans; Indoles; Membrane Microdomains; Piperidines; Polyunsaturated Alkamides; Proto-Oncogene Proteins c-akt; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Rimonabant

2011